Roberts M Scot's Form 4 filing
Altimmune, Inc. (ALT) · filed Jun 30, 2022
- Accession no.
- 0001104659-22-076291
- Filed
- Jun 30, 2022
- Trade date
- Jun 29, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $65.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Roberts M ScotCIK 0001705905 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2022 | Common Stock, par value $0.0001 | MOption exerciseAcquired | +5,462 | $2.60 | +$14,201.2 | 23,162 | Direct | |
| Jun 29, 2022 | Common Stock, par value $0.0001 | SSaleDisposed | −5,462 | $12.00 | −$65,544 | 17,700 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2022 | Common Stock, par value $0.0001 | MOption exerciseDisposed | −5,462 | $0.00 | $0 | 12,769 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.